Kaisa Health Group Holdings Ltd. has announced its interim results for the six months ended 30 June 2025. The company reported total revenue of HK$69.577 million, a decrease from HK$88.516 million in the same period in 2024. The decline in revenue primarily stems from the dental business segment, which saw revenue drop to HK$66.433 million from HK$85.888 million in the prior year. Conversely, the health care business segment experienced a slight increase in revenue, reaching HK$3.144 million compared to HK$2.628 million in 2024. The overall loss before income tax for the period was HK$9.334 million, a reversal from a segment profit before depreciation and amortisation of HK$3.483 million in the previous year. The dental business segment reported a segment operating loss of HK$16.658 million, whereas the health care business segment recorded a segment operating profit of HK$757,000. The results reflect challenges in the dental business operations, contributing to the overall financial performance for the period. No specific outlook or guidance for future periods was provided in the announcement.